Clinical Trial Update: Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Frequency Modulated Neural Stimulation (FREMS) for painful diabetic neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Painful Diabetic Neuropathy

Snippet

Sponsor: Lorenz Biotech S.p.A. | Conditions: Diabetic Neuropathy, Painful | Phase 4 | Status: COMPLETED